Health-related content. Aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before making decisions. .

Mole Checker & Scanner: DermAi

Mole Checker & Scanner: DermAi

By PALMX APPS

DermAi is an AI-powered skin analysis and mole monitoring tool for iOS and Android that tracks skin changes and evaluates skincare ingredients.

The App DNA

What makes this app unique?

It removes the cognitive cost of manual skin monitoring by providing visual risk levels for spots, serving users who want to stay proactive about skin health between professional appointments.

For Individuals interested in proactive skin health monitoring and skincare ingredient analysis.

What does it look like?

Key features

AI Mole Scanneredge

Image analysis tool providing visual risk levels for skin spots and moles.

Skin Trackingstandard

Photo-based monitoring system with reminders to document changes in skin spots over time.

Cosmetic Scanneredge

Ingredient checker to evaluate skincare product suitability for specific skin types.

How much does it cost?

freemiumFree tier with core scanning and trackingIn-app purchases available

Freemium model utilizing in-app purchases to monetize a health-focused utility tool.

Velocity

Maintenance developmentperformanceopaqueShow more...

The app maintains a maintenance-level cadence, shipping only one release in the observed window. The latest release focuses exclusively on technical updates and performance improvements rather than new features or content. Development appears to be in a stable maintenance phase, with no evidence of live operations or feature expansion. The publisher utilizes opaque release notes, providing no specific details on the nature of the technical improvements.

See all version history

Who built it?

PALMX APPS

7 apps tracked · Health & Fitness

Learn German for beginnersLearn German for beginnersMaster English - ENGOMaster English - ENGOMultiplication Games for kidsMultiplication Games for kidsLearn Korean OfflineLearn Korean OfflineLearn English with booksLearn English with booksMole Checker & Scanner: DermAiMole Checker & Scanner: DermAi
Explore the full publisher profile

User Sentiment

What do users think recently?

The recent review mood reads frustrated. Users appreciate the core application interface provides a simple and straightforward experience for users who successfully access the tool.

How are ratings & reviews evolving?

Google Play
3.86 · 389
App Store
4.32 · 31

What users say, by theme

What Users Love
  • The core application interface provides a simple and straightforward experience for users who successfully access the tool
What Frustrates Users
  • The mandatory subscription trial wall prevents users from evaluating the core functionality before committing to payment
+ 1 more theme

7 of 7 recent reviews analyzed · limited sample · Frustrated overall

Read the full review analysis

Unlock 1 more frustration theme, each backed by review evidence.

Access the full report for free

Competition

Competitive landscape for Mole Checker & Scanner: DermAi

How's the Health & Fitness market?

DermAi maintains a 4.32 rating on iOS and a 3.86 rating on Android. The rating gap between platforms, combined with a 14-day maintenance-only update cadence, signals that the Android experience is currently under-optimized relative to the iOS build.

Read the market outlook

The rivals identified

Unlock the deeper market read.

Access the full report for free

The Analyst's Read

Key takeaways for Mole Checker & Scanner: DermAi

Where is it heading?

The health-utility market is consolidating around tools that provide immediate, reliable feedback without aggressive paywalls. DermAi is currently exposed due to technical instability and a restrictive trial model, which will likely accelerate churn into the next quarter.

  • Technical blockers in the onboarding flow prevent new users from accessing the tool, which directly erodes the install-to-active conversion rate.
  • Maintenance-only update cadence without feature expansion leaves the app vulnerable to more active competitors in the health-utility space.

The SWOT

Core Strengths
  • AI-powered image analysis provides low-friction skin monitoring
Critical Frictions 2 weaknesses inside
Growth Levers
  • Transparent pricing could reduce refund-surge risk
Market Threats 1 threat identified

Next best moves

1 Invest · 1 Pivot

Fix onboarding button responsiveness because it is the top-cited technical blocker → increase new-user retention

+ 1 more prioritized move

The counter-intuitive read

The high refund-surge risk from the trial wall is a secondary problem…

Read the full take

Since the last report: The competitive outlook has shifted to declining due to persistent onboarding technical blockers and an emerging rating disparity between iOS and Android platforms. The app remains in a maintenance-only development phase, failing to address the primary user-acquisition friction points identified in the previous period.

Bottom line

Fixing the onboarding responsiveness is the priority, as the current technical blocker prevents users from ever reaching the value proposition. Resolving this will stabilize the install-to-active funnel before the team attempts to optimize the trial-wall conversion.

Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.

Access the full report for free

Sources

  1. [1] Play Store, source
  2. [2] App Store, source

Report last updated

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Mole Checker & Scanner: DermAi, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

What's new

The competitive outlook has shifted to declining due to persistent onboarding technical blockers and an emerging rating disparity between iOS and Android platforms. The app remains in a maintenance-only development phase, failing to address the primary user-acquisition friction points identified in the previous period.

shifted

Platform-specific rating visibility

added

Feature obsolescence threat

declined

Outlook trend downgrade

Cite this report

Marlvel.ai. “Mole Checker & Scanner: DermAi Intelligence Report.” Updated Aug 5, 2026. https://marlvel.ai/apps/mole-checker-scanner-dermai

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0